| 83.91 Delayed Data As of May 22 |  +1.52 / +1.84%Today’s Change | 64.76 Today|||52-Week Range 86.27 | +9.17% Year-to-Date |
| Here's Why Array BioPharma Is Surging Today May 21 / MotleyFool.comFOO - Paid Partner Content | Ionis Pharmaceuticals Is 40% of the Way There May 14 / MotleyFool.com - Paid Partner Content |
| These 3 Major Drug Manufacturers Are Strong Performers May 21 / GuruFocus NewsGURU - Paid Partner Content | Generic Drugmakers Face Antitrust Suit Alleging Price Fixing May 14 / Zacks.com - Paid Partner Content |
| Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study May 20 / Zacks.comZAK - Paid Partner Content | Regeneron (REGN) Gets FDA Nod for Eylea Label Expansion May 14 / Zacks.com - Paid Partner Content |
| Ligand Grants Preclinical Candidate Rights to UK-based Firm May 20 / Zacks.comZAK - Paid Partner Content | Tilray (TLRY) to Report Q1 Earnings: What's in the Cards? May 11 / Zacks.com - Paid Partner Content |
| The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer May 15 / Zacks.com - Paid Partner Content | Tilray (TLRY) to Report Q1 Earnings: What's in the Cards? May 10 / Zacks.com - Paid Partner Content |
| Previous close | 82.39 |
| Today’s open | 82.78 |
| Day’s range | 82.64 - 84.06 |
| Volume | 2,354,468 |
| Average volume (3 months) | 2,381,531 |
| Market cap | $190.2B |
| Earnings growth (last year) | +65.34% |
| Earnings growth (this year) | +6.24% |
| Earnings growth (next 5 years) | +6.80% |
| Revenue growth (last year) | +5.41% |
| P/E ratio | 15.7 |
| Price/Sales | 3.87 |
| Price/Book | 2.43 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +1.48 | +1.86% |
| PFEPfizer | +0.32 | +0.77% |
| ABTAbbott Laboratories | +0.23 | +0.30% |
| ABBVAbbVie | +0.71 | +0.88% |
| Next reporting date | July 18, 2019 |
| EPS forecast (this quarter) | $1.20 |
| Annual revenue (last year) | $52.0B |
| Annual profit (last year) | $12.6B |
| Net profit margin | 24.30% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer Vasant Narasimhan |
Chief Financial Officer Harry Werner Kirsch |
Corporate headquarters Basel, Basel-stadt (basle Town) |
